Loading…

On the Mechanism of Levosimendan-Induced Dopamine Release in the Striatum of Freely Moving Rats

The Ca2+ sensitizer levosimendan (LEV) improves myocardial contractility by enhancing the sensitivity of the contractile apparatus to Ca2+. In addition, LEV promotes Ca2+ entry through L-type channels in human cardiac myocytes. In this study, which was performed using microdialysis, infusion of LEV...

Full description

Saved in:
Bibliographic Details
Published in:Journal of Pharmacological Sciences 2004, Vol.95(3), pp.299-304
Main Authors: Rocchitta, Gaia, Delogu, M. Rosaria, Migheli, Rossana, Solinas, Luigi, Susini, Giuseppe, Desole, Maria S., Miele, Egidio, Miele, Maddalena, Serra, Pier Andrea
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c739t-6fc3adc02975d5ec58c04c8bd9ec8c83b437bcdb3e2c916b9b4476d8e5747dd03
cites cdi_FETCH-LOGICAL-c739t-6fc3adc02975d5ec58c04c8bd9ec8c83b437bcdb3e2c916b9b4476d8e5747dd03
container_end_page 304
container_issue 3
container_start_page 299
container_title Journal of Pharmacological Sciences
container_volume 95
creator Rocchitta, Gaia
Delogu, M. Rosaria
Migheli, Rossana
Solinas, Luigi
Susini, Giuseppe
Desole, Maria S.
Miele, Egidio
Miele, Maddalena
Serra, Pier Andrea
description The Ca2+ sensitizer levosimendan (LEV) improves myocardial contractility by enhancing the sensitivity of the contractile apparatus to Ca2+. In addition, LEV promotes Ca2+ entry through L-type channels in human cardiac myocytes. In this study, which was performed using microdialysis, infusion of LEV at 0.25 μM for 160 min increased dopamine (DA) concentrations (up to fivefold baseline) in dialysates from the striatum of freely moving rats. Ca2+ omission from the perfusion fluid abolished baseline DA release and greatly decreased LEV-induced DA release. Reintroduction of Ca2+ in the perfusion fluid restored LEV-induced DA release. Chelation of intracellular Ca2+ by co-infusing 1,2-bis (o-amino-phenoxy)ethane-N,N,N′,N′-tetraacetic acid tetra (acetoxymethyl) ester (BAPTA-AM, 0.2 mM) did not affect basal DA release and scarcely affected LEV-induced increases in dialysate DA. In addition, co-infusion of the L-type (Cav 1.1 – 1.3) voltage-sensitive Ca2+-channel inhibitor nifedipine failed to inhibit LEV-induced increases in dialysate DA, which, in contrast, was inhibited by co-infusion of the N-type (Cav 2.2) voltage-sensitive Ca2+-channel inhibitor ω-conotoxin GVIA. We conclude that LEV promotes striatal extracellular Ca2+ entry through N-type Ca2+ channels with a consequent increase in DA release.
doi_str_mv 10.1254/jphs.fpe04003x
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_07707841016e49ad943f37794ddc60b1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1347861319324089</els_id><doaj_id>oai_doaj_org_article_07707841016e49ad943f37794ddc60b1</doaj_id><sourcerecordid>66738223</sourcerecordid><originalsourceid>FETCH-LOGICAL-c739t-6fc3adc02975d5ec58c04c8bd9ec8c83b437bcdb3e2c916b9b4476d8e5747dd03</originalsourceid><addsrcrecordid>eNpVUk1vEzEQXSEQLYUrR7Qnbgn-2rV9A7VNiZSqqIDEzfLas4mjXTvYuxH99zjZNIiLx_K8eeN5b4riPUZzTCr2abvbpHm7A8QQon9eFJeYMj4TNRMvz3dML4o3KW0RIgLh-nVxgSvCCUHsslAPvhw2UN6D2WjvUl-GtlzBPiTXg7faz5bejgZseRN2unceykfoQCco3VT5fYhOD-OxcBEBuqfyPuydX5ePekhvi1et7hK8O8Wr4ufi9sf119nq4W55_WU1M5zKYVa3hmprEJG8shWYShjEjGisBCOMoA2jvDG2oUCMxHUjG8Z4bQVUnHFrEb0qlhOvDXqrdtH1Oj6poJ06PoS4VjoOznSgEOeIC4azFMCktpLRlnIumbWmRg3OXB8nrl0Mv0dIg-pdMtB12kMYk6prTgUhNAPnE9DEkFKE9twYI3WwRx3sUYtvt0d7fuWCDyfmsenB_oOf_MiAuwmQs87oLvguS662YYw-y6dMWyfjwCuCEFMIyQrRHLDKykmFKMpjccJElZk-T0zbNOg1nFs9q3D8mawUnY5D-XMqb0JU4DOFmCggG7d3ENWxd14GF8EMWVn3_6DnPaR_Afd9zZE</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>66738223</pqid></control><display><type>article</type><title>On the Mechanism of Levosimendan-Induced Dopamine Release in the Striatum of Freely Moving Rats</title><source>ScienceDirect Journals</source><creator>Rocchitta, Gaia ; Delogu, M. Rosaria ; Migheli, Rossana ; Solinas, Luigi ; Susini, Giuseppe ; Desole, Maria S. ; Miele, Egidio ; Miele, Maddalena ; Serra, Pier Andrea</creator><creatorcontrib>Rocchitta, Gaia ; Delogu, M. Rosaria ; Migheli, Rossana ; Solinas, Luigi ; Susini, Giuseppe ; Desole, Maria S. ; Miele, Egidio ; Miele, Maddalena ; Serra, Pier Andrea ; Faculty of Medicine ; Department of Pharmacology ; Italy ; London ; UK ; St. Mary's Hospital ; Institute of Anesthesiology ; University of Sassari ; Department of Psychiatry</creatorcontrib><description>The Ca2+ sensitizer levosimendan (LEV) improves myocardial contractility by enhancing the sensitivity of the contractile apparatus to Ca2+. In addition, LEV promotes Ca2+ entry through L-type channels in human cardiac myocytes. In this study, which was performed using microdialysis, infusion of LEV at 0.25 μM for 160 min increased dopamine (DA) concentrations (up to fivefold baseline) in dialysates from the striatum of freely moving rats. Ca2+ omission from the perfusion fluid abolished baseline DA release and greatly decreased LEV-induced DA release. Reintroduction of Ca2+ in the perfusion fluid restored LEV-induced DA release. Chelation of intracellular Ca2+ by co-infusing 1,2-bis (o-amino-phenoxy)ethane-N,N,N′,N′-tetraacetic acid tetra (acetoxymethyl) ester (BAPTA-AM, 0.2 mM) did not affect basal DA release and scarcely affected LEV-induced increases in dialysate DA. In addition, co-infusion of the L-type (Cav 1.1 – 1.3) voltage-sensitive Ca2+-channel inhibitor nifedipine failed to inhibit LEV-induced increases in dialysate DA, which, in contrast, was inhibited by co-infusion of the N-type (Cav 2.2) voltage-sensitive Ca2+-channel inhibitor ω-conotoxin GVIA. We conclude that LEV promotes striatal extracellular Ca2+ entry through N-type Ca2+ channels with a consequent increase in DA release.</description><identifier>ISSN: 1347-8613</identifier><identifier>EISSN: 1347-8648</identifier><identifier>DOI: 10.1254/jphs.fpe04003x</identifier><identifier>PMID: 15272204</identifier><language>eng</language><publisher>Japan: Elsevier B.V</publisher><subject>Animals ; Calcium - metabolism ; Calcium Channels, L-Type - metabolism ; Calcium Channels, N-Type - metabolism ; calcium entry ; Chromatography, High Pressure Liquid ; Corpus Striatum - metabolism ; Dopamine - biosynthesis ; Dopamine - metabolism ; Dopamine Agonists - pharmacology ; Hydrazones - pharmacology ; levosimendan ; Male ; Microdialysis ; Pyridazines - pharmacology ; Rats ; Rats, Wistar ; Simendan ; striatal dopamine ; Time Factors</subject><ispartof>Journal of Pharmacological Sciences, 2004, Vol.95(3), pp.299-304</ispartof><rights>2004 Elsevier B.V.</rights><rights>The Japanese Pharmacological Society 2004</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c739t-6fc3adc02975d5ec58c04c8bd9ec8c83b437bcdb3e2c916b9b4476d8e5747dd03</citedby><cites>FETCH-LOGICAL-c739t-6fc3adc02975d5ec58c04c8bd9ec8c83b437bcdb3e2c916b9b4476d8e5747dd03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1347861319324089$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,3549,4024,27923,27924,27925,45780</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15272204$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rocchitta, Gaia</creatorcontrib><creatorcontrib>Delogu, M. Rosaria</creatorcontrib><creatorcontrib>Migheli, Rossana</creatorcontrib><creatorcontrib>Solinas, Luigi</creatorcontrib><creatorcontrib>Susini, Giuseppe</creatorcontrib><creatorcontrib>Desole, Maria S.</creatorcontrib><creatorcontrib>Miele, Egidio</creatorcontrib><creatorcontrib>Miele, Maddalena</creatorcontrib><creatorcontrib>Serra, Pier Andrea</creatorcontrib><creatorcontrib>Faculty of Medicine</creatorcontrib><creatorcontrib>Department of Pharmacology</creatorcontrib><creatorcontrib>Italy</creatorcontrib><creatorcontrib>London</creatorcontrib><creatorcontrib>UK</creatorcontrib><creatorcontrib>St. Mary's Hospital</creatorcontrib><creatorcontrib>Institute of Anesthesiology</creatorcontrib><creatorcontrib>University of Sassari</creatorcontrib><creatorcontrib>Department of Psychiatry</creatorcontrib><title>On the Mechanism of Levosimendan-Induced Dopamine Release in the Striatum of Freely Moving Rats</title><title>Journal of Pharmacological Sciences</title><addtitle>J Pharmacol Sci</addtitle><description>The Ca2+ sensitizer levosimendan (LEV) improves myocardial contractility by enhancing the sensitivity of the contractile apparatus to Ca2+. In addition, LEV promotes Ca2+ entry through L-type channels in human cardiac myocytes. In this study, which was performed using microdialysis, infusion of LEV at 0.25 μM for 160 min increased dopamine (DA) concentrations (up to fivefold baseline) in dialysates from the striatum of freely moving rats. Ca2+ omission from the perfusion fluid abolished baseline DA release and greatly decreased LEV-induced DA release. Reintroduction of Ca2+ in the perfusion fluid restored LEV-induced DA release. Chelation of intracellular Ca2+ by co-infusing 1,2-bis (o-amino-phenoxy)ethane-N,N,N′,N′-tetraacetic acid tetra (acetoxymethyl) ester (BAPTA-AM, 0.2 mM) did not affect basal DA release and scarcely affected LEV-induced increases in dialysate DA. In addition, co-infusion of the L-type (Cav 1.1 – 1.3) voltage-sensitive Ca2+-channel inhibitor nifedipine failed to inhibit LEV-induced increases in dialysate DA, which, in contrast, was inhibited by co-infusion of the N-type (Cav 2.2) voltage-sensitive Ca2+-channel inhibitor ω-conotoxin GVIA. We conclude that LEV promotes striatal extracellular Ca2+ entry through N-type Ca2+ channels with a consequent increase in DA release.</description><subject>Animals</subject><subject>Calcium - metabolism</subject><subject>Calcium Channels, L-Type - metabolism</subject><subject>Calcium Channels, N-Type - metabolism</subject><subject>calcium entry</subject><subject>Chromatography, High Pressure Liquid</subject><subject>Corpus Striatum - metabolism</subject><subject>Dopamine - biosynthesis</subject><subject>Dopamine - metabolism</subject><subject>Dopamine Agonists - pharmacology</subject><subject>Hydrazones - pharmacology</subject><subject>levosimendan</subject><subject>Male</subject><subject>Microdialysis</subject><subject>Pyridazines - pharmacology</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Simendan</subject><subject>striatal dopamine</subject><subject>Time Factors</subject><issn>1347-8613</issn><issn>1347-8648</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNpVUk1vEzEQXSEQLYUrR7Qnbgn-2rV9A7VNiZSqqIDEzfLas4mjXTvYuxH99zjZNIiLx_K8eeN5b4riPUZzTCr2abvbpHm7A8QQon9eFJeYMj4TNRMvz3dML4o3KW0RIgLh-nVxgSvCCUHsslAPvhw2UN6D2WjvUl-GtlzBPiTXg7faz5bejgZseRN2unceykfoQCco3VT5fYhOD-OxcBEBuqfyPuydX5ePekhvi1et7hK8O8Wr4ufi9sf119nq4W55_WU1M5zKYVa3hmprEJG8shWYShjEjGisBCOMoA2jvDG2oUCMxHUjG8Z4bQVUnHFrEb0qlhOvDXqrdtH1Oj6poJ06PoS4VjoOznSgEOeIC4azFMCktpLRlnIumbWmRg3OXB8nrl0Mv0dIg-pdMtB12kMYk6prTgUhNAPnE9DEkFKE9twYI3WwRx3sUYtvt0d7fuWCDyfmsenB_oOf_MiAuwmQs87oLvguS662YYw-y6dMWyfjwCuCEFMIyQrRHLDKykmFKMpjccJElZk-T0zbNOg1nFs9q3D8mawUnY5D-XMqb0JU4DOFmCggG7d3ENWxd14GF8EMWVn3_6DnPaR_Afd9zZE</recordid><startdate>2004</startdate><enddate>2004</enddate><creator>Rocchitta, Gaia</creator><creator>Delogu, M. Rosaria</creator><creator>Migheli, Rossana</creator><creator>Solinas, Luigi</creator><creator>Susini, Giuseppe</creator><creator>Desole, Maria S.</creator><creator>Miele, Egidio</creator><creator>Miele, Maddalena</creator><creator>Serra, Pier Andrea</creator><general>Elsevier B.V</general><general>The Japanese Pharmacological Society</general><general>Elsevier</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>DOA</scope></search><sort><creationdate>2004</creationdate><title>On the Mechanism of Levosimendan-Induced Dopamine Release in the Striatum of Freely Moving Rats</title><author>Rocchitta, Gaia ; Delogu, M. Rosaria ; Migheli, Rossana ; Solinas, Luigi ; Susini, Giuseppe ; Desole, Maria S. ; Miele, Egidio ; Miele, Maddalena ; Serra, Pier Andrea</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c739t-6fc3adc02975d5ec58c04c8bd9ec8c83b437bcdb3e2c916b9b4476d8e5747dd03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Animals</topic><topic>Calcium - metabolism</topic><topic>Calcium Channels, L-Type - metabolism</topic><topic>Calcium Channels, N-Type - metabolism</topic><topic>calcium entry</topic><topic>Chromatography, High Pressure Liquid</topic><topic>Corpus Striatum - metabolism</topic><topic>Dopamine - biosynthesis</topic><topic>Dopamine - metabolism</topic><topic>Dopamine Agonists - pharmacology</topic><topic>Hydrazones - pharmacology</topic><topic>levosimendan</topic><topic>Male</topic><topic>Microdialysis</topic><topic>Pyridazines - pharmacology</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Simendan</topic><topic>striatal dopamine</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rocchitta, Gaia</creatorcontrib><creatorcontrib>Delogu, M. Rosaria</creatorcontrib><creatorcontrib>Migheli, Rossana</creatorcontrib><creatorcontrib>Solinas, Luigi</creatorcontrib><creatorcontrib>Susini, Giuseppe</creatorcontrib><creatorcontrib>Desole, Maria S.</creatorcontrib><creatorcontrib>Miele, Egidio</creatorcontrib><creatorcontrib>Miele, Maddalena</creatorcontrib><creatorcontrib>Serra, Pier Andrea</creatorcontrib><creatorcontrib>Faculty of Medicine</creatorcontrib><creatorcontrib>Department of Pharmacology</creatorcontrib><creatorcontrib>Italy</creatorcontrib><creatorcontrib>London</creatorcontrib><creatorcontrib>UK</creatorcontrib><creatorcontrib>St. Mary's Hospital</creatorcontrib><creatorcontrib>Institute of Anesthesiology</creatorcontrib><creatorcontrib>University of Sassari</creatorcontrib><creatorcontrib>Department of Psychiatry</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Journal of Pharmacological Sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rocchitta, Gaia</au><au>Delogu, M. Rosaria</au><au>Migheli, Rossana</au><au>Solinas, Luigi</au><au>Susini, Giuseppe</au><au>Desole, Maria S.</au><au>Miele, Egidio</au><au>Miele, Maddalena</au><au>Serra, Pier Andrea</au><aucorp>Faculty of Medicine</aucorp><aucorp>Department of Pharmacology</aucorp><aucorp>Italy</aucorp><aucorp>London</aucorp><aucorp>UK</aucorp><aucorp>St. Mary's Hospital</aucorp><aucorp>Institute of Anesthesiology</aucorp><aucorp>University of Sassari</aucorp><aucorp>Department of Psychiatry</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>On the Mechanism of Levosimendan-Induced Dopamine Release in the Striatum of Freely Moving Rats</atitle><jtitle>Journal of Pharmacological Sciences</jtitle><addtitle>J Pharmacol Sci</addtitle><date>2004</date><risdate>2004</risdate><volume>95</volume><issue>3</issue><spage>299</spage><epage>304</epage><pages>299-304</pages><issn>1347-8613</issn><eissn>1347-8648</eissn><abstract>The Ca2+ sensitizer levosimendan (LEV) improves myocardial contractility by enhancing the sensitivity of the contractile apparatus to Ca2+. In addition, LEV promotes Ca2+ entry through L-type channels in human cardiac myocytes. In this study, which was performed using microdialysis, infusion of LEV at 0.25 μM for 160 min increased dopamine (DA) concentrations (up to fivefold baseline) in dialysates from the striatum of freely moving rats. Ca2+ omission from the perfusion fluid abolished baseline DA release and greatly decreased LEV-induced DA release. Reintroduction of Ca2+ in the perfusion fluid restored LEV-induced DA release. Chelation of intracellular Ca2+ by co-infusing 1,2-bis (o-amino-phenoxy)ethane-N,N,N′,N′-tetraacetic acid tetra (acetoxymethyl) ester (BAPTA-AM, 0.2 mM) did not affect basal DA release and scarcely affected LEV-induced increases in dialysate DA. In addition, co-infusion of the L-type (Cav 1.1 – 1.3) voltage-sensitive Ca2+-channel inhibitor nifedipine failed to inhibit LEV-induced increases in dialysate DA, which, in contrast, was inhibited by co-infusion of the N-type (Cav 2.2) voltage-sensitive Ca2+-channel inhibitor ω-conotoxin GVIA. We conclude that LEV promotes striatal extracellular Ca2+ entry through N-type Ca2+ channels with a consequent increase in DA release.</abstract><cop>Japan</cop><pub>Elsevier B.V</pub><pmid>15272204</pmid><doi>10.1254/jphs.fpe04003x</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1347-8613
ispartof Journal of Pharmacological Sciences, 2004, Vol.95(3), pp.299-304
issn 1347-8613
1347-8648
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_07707841016e49ad943f37794ddc60b1
source ScienceDirect Journals
subjects Animals
Calcium - metabolism
Calcium Channels, L-Type - metabolism
Calcium Channels, N-Type - metabolism
calcium entry
Chromatography, High Pressure Liquid
Corpus Striatum - metabolism
Dopamine - biosynthesis
Dopamine - metabolism
Dopamine Agonists - pharmacology
Hydrazones - pharmacology
levosimendan
Male
Microdialysis
Pyridazines - pharmacology
Rats
Rats, Wistar
Simendan
striatal dopamine
Time Factors
title On the Mechanism of Levosimendan-Induced Dopamine Release in the Striatum of Freely Moving Rats
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T10%3A37%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=On%20the%20Mechanism%20of%20Levosimendan-Induced%20Dopamine%20Release%20in%20the%20Striatum%20of%20Freely%20Moving%20Rats&rft.jtitle=Journal%20of%20Pharmacological%20Sciences&rft.au=Rocchitta,%20Gaia&rft.aucorp=Faculty%20of%20Medicine&rft.date=2004&rft.volume=95&rft.issue=3&rft.spage=299&rft.epage=304&rft.pages=299-304&rft.issn=1347-8613&rft.eissn=1347-8648&rft_id=info:doi/10.1254/jphs.fpe04003x&rft_dat=%3Cproquest_doaj_%3E66738223%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c739t-6fc3adc02975d5ec58c04c8bd9ec8c83b437bcdb3e2c916b9b4476d8e5747dd03%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=66738223&rft_id=info:pmid/15272204&rfr_iscdi=true